Loading…

Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-b signal transduction

a-[ordm Significant correlation between ATBF1 and RUNX3 nuclear localization in gastric cancer. a-[ordm Co-IP reveals a physical association between ATBF1 and RUNX3. a-[ordm ATBF1 and RUNX3 up-regulates p21 promoter activity synergistically. a-[ordm TGF-b1 induces endogenous ATBF1 and RUNX3 nuclear...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical and biophysical research communications 2010-07, Vol.398 (2), p.321-325
Main Authors: Mabuchi, Motoshi, Kataoka, Hiromi, Miura, Yutaka, Kim, Tae-Sun, Kawaguchi, Makoto, Ebi, Masahide, Tanaka, Mamoru, Mori, Yoshinori, Kubota, Eiji, Mizushima, Takashi, Shimura, Takaya, Mizoshita, Tsutomu, Tanida, Satoshi, Kamiya, Takeshi, Asai, Kiyofumi, Joh, Takashi
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:a-[ordm Significant correlation between ATBF1 and RUNX3 nuclear localization in gastric cancer. a-[ordm Co-IP reveals a physical association between ATBF1 and RUNX3. a-[ordm ATBF1 and RUNX3 up-regulates p21 promoter activity synergistically. a-[ordm TGF-b1 induces endogenous ATBF1 and RUNX3 nuclear translocation. Background and aims: AT motif binding factor 1 (ATBF1), a homeotic transcription factor, was identified as a tumor suppressor, and loss of heterozygosity at ATBF1 locus occurs frequently in gastric cancers. We previously showed that ATBF1 expression inversely correlated with the malignant character of gastric cancer and that ATBF1 enhanced the promoter activity of p21 Waf1/Cip1. We also found that ATBF1 moves between cytoplasm and nucleus, but the precise mechanism of translocation is unknown. In this study, we investigated the mechanism of ATBF1 translocation to the nucleus with the runt domain transcription factor 3 (RUNX3) in cooperation with TGF-b signal transduction. Materials and methods: To analyze the expression of ATBF1 and RUNX3 in gastric cancer cells, we performed immunohistochemistry on 98 resected gastric cancer tissue samples and scored the nuclear staining intensity as grade 0 to grade 5. Co-immunoprecipitation (co-IP) of ATBF1 and RUNX3 was performed. Dual luciferase assays were performed by transfecting ATBF1 and RUNX3 with a p21 Waf1/Cip1 reporter vector. To investigate the nuclear translocation of endogenous ATBF1 and RUNX3 in response to TGF-b signal, we examined the subcellular localization of ATBF1 and RUNX3 in gastric cancer cells treated with recombinant TGF-b1 using confocal laser scanning microscopy. Results: Strong immunohistochemical nuclear staining of ATBF1 was observed in 37 (37.8%) of the gastric cancer tissue samples, and RUNX3 nuclear staining was observed in 15 (15.3%). There was a statistically significant correlation between ATBF1 and RUNX3 nuclear localization (rs=0.433, p
ISSN:0006-291X
DOI:10.1016/j.bbrc.2010.06.090